ACRIPAB- Trial: Anti Coagulation Regimen In High Risk PAtients for Bleeding
Status:
Completed
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
To determine the safety/efficacy of Bivallirudin Vs unfractionated heparin (UFH) on top of
dual antiplatelet therapy in patients with high tendency for bleeding during urgent and
elective PCI.